Accelerating health sector decarbonisation through medicines carbon footprinting

Medicines are a major contributor to the NHS’ carbon footprint, requiring targeted, data-driven action to meet legislated net zero commitments

Independent, standardised medicines carbon footprint data can support decarbonisation efforts, but clear governance is required to ensure data are used appropriately and to avoid unintended consequences

Embedding carbon considerations into product development and health technology assessment can unlock sustainability by design, aligning improved health outcomes with sustainability and economic growth

Timely action offers an opportunity for the UK to consolidate its leadership in healthcare decarbonisation and shape global standards for sustainable medicines